Neuromuscular Disease News

The Parkinson’s Foundation has expanded its PD GENEration study, a national initiative that offers no-cost genetic testing and counseling to those with Parkinson’s disease, to 23 actively enrolling participant sites.

Pfizer revealed plans to open sites in the U.S. for a phase 3 study evaluating an investigational mini-dystrophin gene therapy in ambulatory patients with Duchenne muscular dystrophy.

SEATTLE — Patients with ALS who were treated with CNM-Au8 — a gold nanocrystal suspension — showed improvements in survival, a speaker said at the 2022 American Academy of Neurology annual meeting.

SEATTLE — Fatigue is a frequent concern for patients with MS in the United Kingdom and has multiple predictors, according to a presenter at the 2022 American Academy of Neurology annual meeting.

SEATTLE — In a first-in-human study, participants with paralysis who received an endovascular brain-computer implant were able to effectively operate a computer, researchers reported at the American Academy of Neurology annual meeting.

The combination of physiotherapy and psychological interventions, including cognitive behavioral therapy and pain education, were effective in treating chronic lower back pain, researchers reported in BMJ.

Natalia S. Rost, MD, MPH, chair of the AAN science committee, led a discussion to highlight select studies being presented at the AAN’s annual meeting April 2-7 in Seattle.

Rates of chronic pain, depression and anxiety decreased and were sustained over 12 months following the use of an app-based program from Hinge Health, the company announced.

Incidence rates for Bell’s palsy, encephalomyelitis and Guillain- Barré syndrome were higher in unvaccinated people with SARS-CoV-2 infection compared with those vaccinated against COVID-19, researchers reported in BMJ.

The American Academy of Neurology noted palliative care can benefit individuals with neurologic diseases and may lead to longer survival when provided early in the disease process.